🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Acute Ischemic Stroke Patients

Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion NCT06633809n/a1 site📍 Hangzhou Sir Run Run Shaw Hospital · Tests: Immediate endovascular therapy Cerebrovascular Disease: Quality of Life (CODE: QoL) NCT06443268n/a1 site📍 Zurich University of Zurich · Tests: questionnaire, hair samples, blood samples, clinical exam The STem Cell-derived Extracellular Vesicle Therapy In Acute Ischemic Stroke (STEVIA) NCT06995625Phase 13 sites📍 Suwon📍 Seoul📍 Seoul S&Ebio Co. Ltd. · Tests: SNE-101 Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) NCT07389460Phase 310 sites📍 Lanzhou📍 Shijiazhuang📍 Zhengzhou First Affiliated Hospital Xi'an Jiaotong University · Tests: Intravenous rhPro-UK, Intravenous placebo, Endovascular thrombectomy Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2) NCT06677970Phase 31 site📍 Seoul Yonsei University · Tests: BP lowering drugs (nicardipine, labetalol, urapidil), BP raising drug (phenylephrine) or BP lowering drugs (nicardipine… Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2) NCT07800572Phase 213 sites📍 Anyang📍 Beijing📍 Huzhou Capital Medical University · Tests: Anisodine Hydrobromide, Anisodine Hydrobromide Placebo Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2 NCT05659160n/a4 sites📍 Tianjin📍 Tianjin📍 Tianjin Tianjin Huanhu Hospital · Tests: Endovascular Therapy Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients NCT06315231Phase 221 sites📍 Fuyang📍 Hefei📍 Hefei Simcere Pharmaceutical Co., Ltd · Tests: Edaravone dexborneol sublingual tablet, Placebo SUMMIT RISE Study of Acute Ischemic Stroke Patients NCT07436156Phase 41 site📍 West Jordan Route 92 Medical, Inc. · Tests: Route 92 Medical Reperfusion Systems Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke NCT05930145NA4 sites📍 Essen📍 Barakaldo📍 Oviedo Fundación EPIC · Tests: Double stentriever, Single stentriever Extending the Time Window for Intravenous Tenecteplase in Patients With Distal Medium Vessel Occlusions Stroke NCT06559436NA1 site📍 Hefei The First Affiliated Hospital of University of Science and … · Tests: Intravenous thrombolysis, Standard medical management Treatment With Endovascular Intervention for STroke Patients With Existing Disability NCT05911568n/a35 sites📍 Birmingham📍 Phoenix📍 Los Angeles University of Cincinnati · Tests: Endovascular Stroke Treatment, Medical Management Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke NCT07509645Phase 330 sites📍 Huaibei📍 Suzhou📍 Heyuan Capital Medical University · Tests: Tocilizumab, Placebo Intravenous Thrombolysis and NOAC NCT06749834Phase 32 sites📍 Hangzhou📍 Taizhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Intravenous thrombolysis HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN) NCT07379190Phase 31 site📍 Weifang Weifang Medical University · Tests: Tirofiban, dual antiplatelet therapy A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well NCT07361302Phase 3257 sites📍 Buenos Aires📍 Ciudad Autonoma Buenos Aires📍 Ciudad Autonoma Buenos Aires Boehringer Ingelheim · Tests: Tenecteplase, Standard of care treatment Thrombectomy Versus Best Medical Management in Large Vessel Occlusion Stroke Patients Presenting Beyond 24 Hours and With Presence of Collateral Flow on CT Angiography NCT06654375NA1 site📍 Tianjin Tianjin Huanhu Hospital · Tests: Endovascular Thrombectomy Rescue Stenting and Intravenous Thrombolysis In Patients With Large Vessel Ischemic Stroke NCT06727006n/a7 sites📍 Bergamo📍 Cesena📍 Lecce ASST Santi Paolo e Carlo Prospective Randomized Observer Blinded Single Center Study Comparing 90-day Functional Outcome in Patients Who Received Intravenous Propofol Infusion Versus Inhalational Sevoflurane for General Anesthesia During Mechanical Thrombectomy in Patients Who Suffered From Acute Ischemic Stroke NCT07001267NA1 site📍 Kansas City University of Kansas Medical Center · Tests: Anesthesia drugs during the surgery Sevoflurane vs. Propofol for General Anesthesia in Patients With Acute Ischemic Stroke Treated With Endovascular Therapy NCT07902791Phase 31 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Sevoflurane, propofol (drug) Predictive Role of sTREM in Endovascular Thrombectomy Outcomes NCT06545591n/a1 site📍 Xuzhou The Affiliated Hospital of Xuzhou Medical University Triage of Patients Presenting Beyond 24 Hours With Acute Ischemic Stroke Due to Large Vessel Occlusions (TRACK-LVO Late) NCT06200753n/a1 site📍 Tianjin Tianjin Huanhu Hospital · Tests: Mechanical Thrombectomy Combined taVNS and tDCS in Subacute Stroke Patients NCT06244914NA1 site📍 Tainan National Cheng-Kung University Hospital · Tests: tDCS stimulation, taVNS stimulation, sham tDCS stimulation, sham taVNS stimulation The Correlation of Intracranial Artery Calcification and Outcomes of Mechanical Thrombectomy NCT06418698n/a1 site📍 Guangzhou Zhujiang Hospital Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY) NCT06157502Phase 382 sites📍 Beijing📍 Chongqing📍 Chongqing Beijing Tiantan Hospital · Tests: Shuxuening Injection, Placebo A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke NCT07205328Phase 21 site📍 Beijing Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Tests: MT200605, MT200605, MT200605, Placebo Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke NCT05604638Phase 338 sites📍 Chuzhou📍 Longyan📍 Nanning Second Affiliated Hospital of Guangxi Medical University · Tests: Tirofiban Hydrochloride, Placebo Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke NCT05691244Phase 354 sites📍 Tucson📍 Carmichael📍 Oxnard Pharmazz, Inc. · Tests: Drug: Normal Saline, Sovateltide Association Between Circulating BDNF Levels and Cardioembolic Strokes in Patients Treated for Ischemic Stroke NCT07624396n/a1 site📍 Dijon Centre Hospitalier Universitaire Dijon · Tests: Circulating BDNF levels measured via blood sample Safety and Efficacy Evaluation of the Ceretrieve Device in the Treatment of AIS Patients NCT06733246NA1 site📍 Heidelberg Ceretrieve Ltd. · Tests: Aspiration 0
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy